Human CD137 Protein, Fc Tag
- 
									
产品编号
KMP2300
 - 
									
别名
肿瘤坏死因子超家族受体9, CD137, ILA
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2300 | 
| Alias | 肿瘤坏死因子超家族受体9, CD137, ILA | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD137 Protein(KMP2300) is produced in HEK293 Cells and the target gene encoding Leu24-Gln186 is expressed with a Fc tag at the C-terminus. | 
| Molecular Name | CD137 | 
| Product Introduction | CD137(4-1BB):重要的共刺激分子,以跨膜形式表达于免疫细胞表面,参与增强免疫应答和细胞存活。 | 
| Molecular Weight | 17.37 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | Q07011 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | Tumor necrosis factor receptor superfamily member 9(TNFRSF9), also known as CD137 and 4-1BB, is an inducible T cell surface protein belonging to the tumor necrosis factor receptor superfamily. It is a single-pass type I membrane protein which contains 4 TNFR-Cys repeats. The human and mouse proteins share 60% amino acid sequence identity. CD137 is expressed by mesenchymal cells, including endothelial cells, chondrocytes, and cells of the central nervous system. CD137 is also broadly expressed by cells of the human immune system, is broadly expressed by cells of the human immune system, including activated CD8+ and CD4+ T cells, activated natural killer(NK) cells, follicular dendritic cells(FDCs) and monocytes. CD137 has diverse roles in the immune response, the one key function is to promote the survival of both T cells and dendritic cells by binding the cognate ligand CD137L(4-1BBL). | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
低速离心:12,000 rpm, 5分钟,去除不溶物。缓冲液置换:使用超滤离心管(如10 kDa截留分子量)浓缩。
可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。
							
							
							
							
						
								0